Market LIVE
Published markets; coverage varies by country
Product profile · United States

OXBRYTA

 ·  Patent Litigation & Settlement History ↓

IngredientVOXELOTOR
Application typeNDA
Application213137
Product001
Dosage formTABLET
RouteORAL
Strength500MG
Approval date2019-11-25
Marketing statusDISCONTINUED
Status event—
ApplicantGLOBAL BLOOD THERAPS
Product source

Current GenericRadar decision

Year2024
SelectionDISQUALIFIED
ReviewFINAL
Anchor typeFDA_MARKET_WITHDRAWAL
Anchor date—
Patent anchor2034-01-29
Exclusivity anchor2026-11-25
Protection date2037-10-12
First Final ANDA—
Status event2024-09-26

GNR judgment: DISQUALIFIED. Reference year: 2024. Anchor type: FDA_MARKET_WITHDRAWAL. Patent anchor: 2034-01-29. Exclusivity anchor: 2026-11-25. Anchor date: not recorded. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
100174912032-12-28DP —NYU
English description not available.
———
100174912032-12-28ORANGE_BOOK —NYU
English description not available.
———
100348792032-12-28DS/DP —NYU
English description not available.
———
100348792032-12-28ORANGE_BOOK —NYU
English description not available.
———
108067332032-12-28DS —YNTRUE_DS
English description not available.
———
108067332032-12-28ORANGE_BOOK —YNTRUE_DS
English description not available.
———
90182102033-11-25DS/DP —YNTRUE_DS
English description not available.
———
90182102033-11-25ORANGE_BOOK —YNTRUE_DS
English description not available.
———
92481992034-01-29U U-2715NYU
English description not available.
———
92481992034-01-29U U-2676NYU
English description not available.
———
92481992034-01-29ORANGE_BOOK U-2676;U-2715NYU
English description not available.
———
107225022035-02-06DP —NNDP
English description not available.
———
107225022035-02-06ORANGE_BOOK —NNDP
English description not available.
———
114527202035-02-06U U-3459NNU
English description not available.
———
114527202035-02-06ORANGE_BOOK U-3459NNU
English description not available.
———
94470712035-02-06DS/DP —NNDP
English description not available.
———
94470712035-02-06ORANGE_BOOK —NNDP
English description not available.
———
110203822036-12-02U U-3133NNU
English description not available.
———
110203822036-12-02U U-3134NNU
English description not available.
———
110203822036-12-02ORANGE_BOOK U-3133;U-3134NNU
English description not available.
———
119446122036-12-02U U-3893NNDP
English description not available.
———
119446122036-12-02ORANGE_BOOK U-3893NNDP
English description not available.
———
104930352037-10-12DP —NNDP
English description not available.
———
104930352037-10-12ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2019-11-252024-11-25English description not available.YY2024-11-25
ODE-281 + ODE-394
Full coverage date: 2024-11-25
Source
ODE-2812019-11-252026-11-25English description not available.NN——Source
ODE-2812019-11-252026-11-25English description not available.NN—
ODE-281 + ODE-394
Full coverage date: —
Source
ODE-3942021-12-172028-12-17English description not available.NN——Source
ODE-3942021-12-172028-12-17English description not available.NN—
ODE-281 + ODE-394
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (15)
TypeDateRoleBasisSource
PATENT2032-12-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-12-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-12-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-11-25HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2034-01-29HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-02-06HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-02-06HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-02-06HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-12-02HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-12-02HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-10-12HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2024-09-26TERMINAL_STATUSEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.